carmustine and kcc 009

carmustine has been researched along with kcc 009 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choi, K; Jackson, EN; Khosla, C; Miller, CR; Piwnica-Worms, D; Rich, KM; Siegel, M; Yuan, L	1

Other Studies

1 other study(ies) available for carmustine and kcc 009

Article	Year
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene, 2007, Apr-19, Volume: 26, Issue:18 Topics: Animals; Brain; Brain Neoplasms; Carmustine; Enzyme Inhibitors; Extracellular Matrix; Female; Fibronectins; Fluorescent Antibody Technique; Glioblastoma; GTP-Binding Proteins; Humans; Isoxazoles; Mice; Mice, Inbred BALB C; Protein Glutamine gamma Glutamyltransferase 2; RNA, Small Interfering; Survival Rate; Transglutaminases; Tumor Cells, Cultured	2007

Article

Year

Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy.

Oncogene, 2007, Apr-19, Volume: 26, Issue:18

Topics: Animals; Brain; Brain Neoplasms; Carmustine; Enzyme Inhibitors; Extracellular Matrix; Female; Fibronectins; Fluorescent Antibody Technique; Glioblastoma; GTP-Binding Proteins; Humans; Isoxazoles; Mice; Mice, Inbred BALB C; Protein Glutamine gamma Glutamyltransferase 2; RNA, Small Interfering; Survival Rate; Transglutaminases; Tumor Cells, Cultured

2007